|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.770 USD | -1.12% |
|
-11.50% | +29.20% |
| Market Cap | 618M 542M 501M 460M 869M 59.58B 883M 5.99B 2.35B 29.15B 2.32B 2.27B 100B | P/E 2026 * |
-2.49x | P/E 2027 * | -2.32x |
|---|---|---|---|---|---|
| Enterprise Value | 432M 379M 350M 322M 608M 41.67B 617M 4.19B 1.64B 20.39B 1.62B 1.59B 70.25B | EV / Sales 2026 * |
64,789x | EV / Sales 2027 * | 35.4x |
| Free-Float |
83.53% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Allogene Therapeutics, Inc.
| 1 day | -1.12% | ||
| 1 week | -11.50% | ||
| Current month | -14.90% | ||
| 1 month | -11.50% | ||
| 3 months | -25.94% | ||
| 6 months | +8.59% | ||
| Current year | +29.20% |
| 1 week | 1.74 |  | 1.94 |
| 1 month | 1.74 | | 2.25 |
| Current year | 1.31 | | 4.46 |
| 1 year | 0.98 | | 4.46 |
| 3 years | 0.86 | | 5.78 |
| 5 years | 0.86 | | 27.86 |
| 10 years | 0.86 | | 55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zachary Roberts
CEO | Chief Executive Officer | 48 | 01/07/2026 |
Geoffrey Parker
DFI | Director of Finance/CFO | 61 | 16/10/2023 |
Benjamin Beneski
CTO | Chief Tech/Sci/R&D Officer | 49 | 28/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Arie Belldegrun
CHM | Chairman | 76 | 01/11/2017 |
Joshua Kazam
BRD | Director/Board Member | 49 | 01/11/2017 |
Franz Humer
BRD | Director/Board Member | 79 | 01/04/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/7/26 | Free | Chief Executive Officer | 610,720 | 0.1769% | ||
| 18/6/26 | Free | Director | 95,400 | 0.0276% | ||
| 18/6/26 | Free | Director | 95,400 | 0.0276% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.12% | -11.50% | +41.60% | -67.28% | 618M | |
| +0.21% | -1.34% | +53.17% | +60.65% | 53.83B | |
| +5.37% | +0.75% | +50.39% | +83.03% | 52.1B | |
| -1.20% | -7.43% | +4.35% | +406.96% | 23.48B | |
| +0.74% | +0.73% | -16.23% | -15.55% | 23.13B | |
| +3.46% | +0.79% | +34.01% | -4.47% | 19.36B | |
| -1.18% | -1.15% | +30.12% | -32.02% | 17.56B | |
| -1.67% | -8.56% | +163.95% | +284.69% | 15.2B | |
| +3.62% | -2.42% | +29.70% | +663.64% | 14.83B | |
| -0.70% | -1.72% | +24.87% | +184.19% | 14.06B | |
| Average | +0.75% | -3.24% | +41.59% | +156.38% | 23.42B | |
| Weighted average by Cap. | +1.47% | -2.37% | +41.46% | +140.30% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.67K 5.85K 5.4K 4.97K 9.38K 643K 9.53K 64.62K 25.33K 315K 25.05K 24.5K 1.08M | 14.59M 12.79M 11.82M 10.88M 20.52M 1.41B 20.85M 141M 55.43M 689M 54.8M 53.61M 2.37B |
| Net income | -197M -173M -160M -147M -277M -19.03B -282M -1.91B -749M -9.31B -741M -725M -32.08B | -231M -203M -187M -172M -325M -22.28B -330M -2.24B -877M -10.9B -868M -849M -37.56B |
| Net Debt | -186M -163M -150M -138M -261M -17.91B -265M -1.8B -705M -8.76B -697M -682M -30.18B | -101M -88.35M -81.66M -75.11M -142M -9.72B -144M -976M -383M -4.76B -378M -370M -16.39B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/07/26 | US$1.770 | -1.12% | 3,421,573 |
| 17/07/26 | US$1.790 | 0.00% | 4,939,744 |
| 16/07/26 | US$1.790 | -5.79% | 6,300,098 |
| 15/07/26 | US$1.900 | +2.70% | 6,039,901 |
| 14/07/26 | US$1.850 | -4.15% | 5,422,350 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALLO Stock
Select your edition
All financial news and data tailored to specific country editions
